These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2434607)

  • 1. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
    Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
    Hastings GZ; Speller SA; Francis MJ
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
    Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
    Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of human rhinovirus serotype 2 (HRV2).
    Verdaguer N; Blaas D; Fita I
    J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
    Hewat EA; Blaas D
    EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
    Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to a peptide of human rhinovirus type 2 with different specificities recognize the same minimum sequence.
    Barnett PV; Rowlands DJ; Campbell RO; Parry NR
    J Gen Virol; 1995 May; 76 ( Pt 5)():1255-61. PubMed ID: 7730811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
    Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
    Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.
    Hewat EA; Marlovits TC; Blaas D
    J Virol; 1998 May; 72(5):4396-402. PubMed ID: 9557730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.
    Barnett PV; Rowlands DJ; Parry NR
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1295-302. PubMed ID: 8393073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2.
    Francis MJ; Hastings GZ; Sangar DV; Clark RP; Syred A; Clarke BE; Rowlands DJ; Brown F
    J Gen Virol; 1987 Oct; 68 ( Pt 10)():2687-91. PubMed ID: 2822846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of canine parvovirus B cell epitopes.
    López de Turiso JA; Cortés E; Ranz A; García J; Sanz A; Vela C; Casal JI
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2445-56. PubMed ID: 1919526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of epitopes of VP2 protein of chicken anemia virus using monoclonal antibodies.
    Wang X; Gao H; Gao Y; Fu C; Wang Z; Lu G; Cheng Y; Wang X
    J Virol Methods; 2007 Aug; 143(2):194-9. PubMed ID: 17481740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
    Tormo J; Blaas D; Parry NR; Rowlands D; Stuart D; Fita I
    EMBO J; 1994 May; 13(10):2247-56. PubMed ID: 8194515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.
    Sherry B; Mosser AG; Colonno RJ; Rueckert RR
    J Virol; 1986 Jan; 57(1):246-57. PubMed ID: 2416951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
    Martínez-Torrecuadrada JL; Casal JI
    Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
    Hwang GY; Li JK
    Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.